Drug profile · INN
copper
PARAGARD T 380A
copper (PARAGARD T 380A) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.
Drug details — copper
- US status
- approved
- Class
- —
- Route
- INTRAUTERINE
- Patents
- 20
- Programs
- 1
- Data quality
- 0.84
Quick answer
copper (PARAGARD T 380A) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 12241902
Probes for detection of copper
granted -
US 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
granted -
US 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted -
US 11000568
Means and methods for treating copper-related diseases
granted -
US 11000502
Antimicrobial compositions comprising copper-hydroxypyrone complexes
granted -
US 10988778
Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders
granted -
US 10383940
Copper-cysteamine and methods of use
granted -
US 10080379
Zinc and copper fortifying composition, a hydrating supplement, and process for preparing the same
granted -
US 10071943
Copper catalyzed [18F]fluorination of iodonium salts
granted -
US 10064942
Copper-cysteamine and methods of use
granted -
US 9593131
Copper-cysteamine and methods of use
granted -
US 8865914
Fluorescent probes for detection of copper
granted -
US 8703987
Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate
granted -
US 8303984
Skin treatment compositions containing copper-pigment complexes
granted -
US 8303985
Skin treatment compositions containing copper-pigment complexes
granted -
US 7758898
Copper lowering treatment of inflammatory and fibrotic diseases
granted -
US 7563920
Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate
granted -
US 7416741
Copper lowering treatment of inflammatory and fibrotic diseases
granted -
US 7253147
Modified serum albumin with reduced affinity for nickel and copper
granted -
US 6855340
Copper lowering treatment of inflammatory and fibrotic diseases
expired
Frequently asked questions
What is copper?
copper (PARAGARD T 380A) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrauterine. Current US regulatory status: approved.
What is the brand name for copper?
PARAGARD T 380A is a marketed brand name for copper. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of copper?
copper has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.